Exhibit 10.2
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR
THE LAWS OF ANY STATE. THEY MAY NOT BE SOLD OR OTHERWISE TRANSFERRED UNLESS THEY
ARE REGISTERED UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR AN
EXEMPTION FROM REGISTRATION IS AVAILABLE. THE SHARES ISSUABLE UPON EXERCISE OF
THESE SECURITIES MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF BY THE
HOLDER EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FILED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND IN COMPLIANCE WITH APPLICABLE SECURITIES
LAWS OF ANY STATE WITH RESPECT THERETO OR IN ACCORDANCE WITH AN OPINION OF
COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER THAT AN EXEMPTION FROM
SUCH REGISTRATION IS AVAILABLE AND ALSO MAY NOT BE SOLD, TRANSFERRED OR
OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE WITH ANY APPLICABLE RULES OF THE
SECURITIES AND EXCHANGE COMMISSION.
                     Warrants
REGEN BIOLOGICS, INC.
WARRANT CERTIFICATE
Warrant to Purchase
Preferred or Common Stock
Date of Issue: March 2, 2007
     This warrant certificate (“Warrant Certificate”) certifies that for value
received                      or registered assigns (the “Holder”) is the owner
of the warrant specified above (the “Warrant”), which entitles the Holder
thereof to purchase, at any time on or before the Expiration Date (hereinafter
defined) (i) up to                      fully paid and non-assessable shares of
Series D Convertible Preferred Stock, $0.01 par value (“Preferred Stock”), of
ReGen Biologics, Inc., a Delaware corporation (the “Company”), or (ii) after the
Mandatory Conversion (as hereinafter defined) of the Preferred Stock, up to
                     fully paid and non-assessable shares of Common Stock, $0.01
par value (“Common Stock”), of ReGen Biologics, Inc., a Delaware corporation
(the “Company”), at the Exercise Price (as defined herein). “Mandatory
Conversion” means the conversion of the Preferred Stock pursuant to Paragraph
7(a) of the Certificate of Designations, Preferences and Rights in the form
attached hereto as Exhibit A.
     1. Warrant; Exercise Price
     This Warrant shall entitle the Holder to purchase up to
(i)                    shares of Preferred Stock of the Company and the purchase
price payable upon exercise of the Warrants shall

 

--------------------------------------------------------------------------------

 

initially be $63.00 per share of Preferred Stock, subject to adjustment as
hereinafter provided (as may be adjusted from time to time, the “Preferred
Exercise Price”) or, (ii) after the Mandatory Conversion of the Preferred Stock,
                    shares of Common Stock of the Company and the purchase price
payable upon exercise of the Warrants shall initially be $0.63 per share of
Common Stock, subject to adjustment as hereinafter provided (as may be adjusted
from time to time, the “Common Exercise Price” and together with the Preferred
Exercise Price, the “Exercise Price”). The Exercise Price and number of shares
of Preferred Stock or, after the Mandatory Conversion, Common Stock, issuable
upon exercise of this Warrant are subject to adjustment as provided in
Article 6.
     2. Exercise; Expiration Date
     2.1 This Warrant is exercisable, at the option of the Holder, at any time
or times after issuance and on or before the Expiration Date (as hereinafter
defined), upon surrender of this Warrant Certificate to the Company together
with a duly completed Notice of Exercise, in the form attached hereto as
Exhibit B, and payment of an amount equal to the product of (i) the Preferred
Exercise Price times the number of shares of Preferred Stock to be acquired, or
(ii) after the Mandatory Conversion, the Common Exercise Price times the number
of shares of Common Stock to be acquired. Payment of the Exercise Price for the
Warrant Shares (as hereinafter defined) shall be in lawful money of the United
States of America, paid by wired transfer or cashier’s check drawn on a United
States bank or pursuant to the terms of Section 9. In the case of exercise of
the Warrant for less than all the Warrant Shares (as hereinafter defined)
represented by this Warrant Certificate, the Company shall cancel the Warrant
Certificate upon the surrender thereof and shall execute and deliver a new
Warrant Certificate for the balance of such Warrant Shares (as hereinafter
defined).
     2.2 The term “Expiration Date” shall mean 5:00 p.m. New York time on
March 2, 2012 or if such date shall in the State of New York be a holiday or a
day on which banks are authorized to close, then 5:00 p.m. New York time the
next following date which in the State of New York is not a holiday or a day on
which banks are authorized to close.
     3. Registration and Transfer on Company Books
     3.1 The Company shall maintain books for the registration and transfer of
the Warrants and the registration and transfer of the shares of Preferred Stock
or, after the Mandatory Conversion, Common Stock, issued upon exercise of the
Warrants.
     3.2 Prior to due presentment for registration of transfer of this Warrant
Certificate, or the shares of Preferred Stock or, after the Mandatory
Conversion, Common Stock, issued upon exercise of the Warrants, the Company may
deem and treat the registered Holder as the absolute owner thereof.
     3.3 Neither this Warrant nor the shares of Preferred Stock or, after the
Mandatory Conversion, Common Stock, issuable upon exercise hereof (the “Warrant
Shares”) have been registered under the Securities Act of 1933, as amended (the
“Act”).

2

--------------------------------------------------------------------------------

 

The Company will not transfer this Warrant or issue or transfer the Warrant
Shares unless (i) there is an effective registration covering such Warrant or
Warrant Shares, as the case may be, under the Act and applicable states
securities laws, (ii) it first receives a letter from an attorney, acceptable to
the Company’s board of directors or its agents, stating that in the opinion of
the attorney the proposed issue or transfer is exempt from registration under
the Act and under all applicable state securities laws, or (iii) the transfer is
made pursuant to Rule 144 under the Act. Subject to the foregoing, this Warrant
Certificate, the Warrant represented hereby, and the Warrant Shares, may be
sold, assigned or otherwise transferred voluntarily by the Holder to officers or
directors of the Holder, to members of such persons’ immediate families, or to
the Holder’s parent or subsidiary corporations. The Company shall register upon
its books any permitted transfer of a Warrant Certificate, upon surrender of
same to the Company with a written instrument of transfer duly executed by the
registered Holder or by a duly authorized attorney. Upon any such registration
of transfer, new Warrant Certificate(s) shall be issued to the transferee(s) and
the surrendered Warrant Certificate shall be canceled by the Company. A Warrant
Certificate may also be exchanged, at the option of the Holder, for new Warrant
Certificates representing in the aggregate the number of Warrant Shares
evidenced by the Warrant Certificate surrendered.
     4. Reservation of Shares
     The Company covenants that it will at all times reserve and keep available
out of its authorized Preferred Stock, or, after the Mandatory Conversion,
Common Stock, solely for the purpose of issue upon exercise of the Warrant, such
number of shares of Preferred Stock or Common Stock as shall then be issuable
upon the exercise of the entire Warrant. The Company covenants that all Warrant
Shares shall be duly and validly issued and, upon payment for such shares as set
forth herein, fully paid and non-assessable and free from all taxes, liens and
charges with respect to the issue thereof, and, with regard to the Common Stock,
that upon issuance such shares shall be listed on each national securities
exchange, if any, on which the other shares of outstanding Common Stock of the
Company are then listed.
     5. Loss or Mutilation
     Upon receipt by the Company of reasonable evidence of the ownership of and
the loss, theft, destruction or mutilation of any Warrant Certificate and, in
the case of loss, theft or destruction, of indemnity reasonably satisfactory to
the Company, or, in the case of mutilation, upon surrender and cancellation of
the mutilated Warrant Certificate, the Company shall execute and deliver in lieu
thereof a new Warrant Certificate representing the number of Warrant Shares
evidenced by the lost, stolen, destroyed or mutilated Warrant Certificate.
     6. Adjustments of Exercise Price and Shares
     6.1 In the event of changes in the outstanding Preferred Stock or Common
Stock of the Company by reason of stock dividends, split-ups, recapitalizations,
reclassifications, combinations or exchanges of shares, separations,
reorganizations, liquidations, consolidation, acquisition of the Company
(whether through merger or acquisition of substantially all the assets or stock
of the Company), or the like, the

3

--------------------------------------------------------------------------------

 

number and class of shares available under the Warrant in the aggregate and the
Exercise Price shall be correspondingly adjusted to give the Holder of the
Warrant, on exercise for the same aggregate Exercise Price, the total number,
class, and kind of shares or other property as the Holder would have owned had
the Warrant been exercised prior to the event and had the Holder continued to
hold such shares until the event requiring adjustment. The form of this Warrant
need not be changed because of any adjustment in the number of Warrant Shares
subject to this Warrant or the Exercise Price provided herein.
     6.2 If at any time or from time to time the holders of all of the shares of
Preferred Stock or, after the Mandatory Conversion, Common Stock, of the Company
(or the holders of all of the shares of stock or other securities at the time
receivable upon the exercise of this Warrant) shall, as a class, have received
or become entitled to receive, without payment therefor:

  (i)   Common Stock or any shares of stock or other securities which are at any
time directly or indirectly convertible into or exchangeable for Common Stock,
or any rights or options to subscribe for, purchase or otherwise acquire any of
the foregoing by way of dividend or other distribution (other than a dividend or
distribution covered in Section 6.1 above),     (ii)   any cash paid or payable
otherwise than as a cash dividend; or     (iii)   Common Stock or additional
stock or other securities or property (including cash) by way of spinoff,
split-up, reclassification, combination of shares or similar corporate
rearrangement (other than shares of Common Stock pursuant to Section 6.1 above),

then, and in each such case, the Holder hereof will, upon the exercise of this
Warrant, be entitled to receive, in addition to the number of shares of
Preferred Stock or, after the Mandatory Conversion, Common Stock receivable
thereupon, and without payment of any additional consideration therefor, the
amount of stock and other securities and property (including cash in the cases
referred to in clauses (ii) and (iii) above) which such Holder would hold on the
date of such exercise had he been the holder of record of such Preferred Stock
or, after the Mandatory Conversion, Common Stock, as of the date on which
holders of Preferred Stock or, after the Mandatory Conversion, Common Stock,
received or became entitled to receive such shares or all other additional stock
and other securities and property.
     6.3 Whenever the number of Warrant Shares purchasable upon the exercise of
the Warrant or the Exercise Price of such Warrant Shares is adjusted, as herein
provided, the Company shall mail to the Holder, at the address of the Holder
shown on the books of the Company, a notice of such adjustment or adjustments,
prepared and signed by the Chief Financial Officer or Secretary of the Company,
which sets forth the number of Warrant Shares purchasable upon the exercise of
each Warrant and the Exercise Price of

4

--------------------------------------------------------------------------------

 

such Warrant Shares after such adjustment, a brief statement of the facts
requiring such adjustment and the computation by which such adjustment was made.
     7. Conversion
     7.1 In lieu of exercise of any portion of the Warrant as provided in
Section 2.1 hereof, the Warrants represented by this Warrant Certificate (or any
portion thereof) may, at the election of the Holder, be converted into the
nearest whole number of shares of Preferred Stock or, after the Mandatory
Conversion, Common Stock, equal to: (1) the product of (a) the number of
Warrants to be so converted, (b) the number of shares of Preferred Stock or,
after the Mandatory Conversion, Common Stock, then issuable upon the exercise of
each Warrant and (c) the excess, if any, of (i) the Preferred Stock Market Price
Per Share (as determined pursuant to Section 8.3) or, after the Mandatory
Conversion, Common Stock Market Price Per Share (as determined pursuant to
Section 8.2) with respect to the date of conversion over (ii) the Exercise Price
in effect on the business day next preceding the date of conversion, divided by
(2) the Preferred Stock Market Price Per Share or, after the Mandatory
Conversion, Common Stock Market Price Per Share with respect to the date of
conversion.
     7.2 The conversion rights provided under this Section 7 may be exercised in
whole or in part and at any time and from time to time while any Warrants remain
outstanding. In order to exercise the conversion privilege, the Holder shall
surrender to the Company, at its offices, this Warrant Certificate accompanied
by a duly completed Notice of Conversion in the form attached hereto as
Exhibit C. The Warrants (or so many thereof as shall have been surrendered for
conversion) shall be deemed to have been converted immediately prior to the
close of business on the day of surrender of such Warrant Certificate for
conversion in accordance with the foregoing provisions. As promptly as
practicable on or after the conversion date, the Company shall issue and shall
deliver to the Holder (i) a certificate or certificates representing the number
of shares of Common Stock to which the Holder shall be entitled as a result of
the conversion, and (ii) if the Warrant Certificate is being converted in part
only, a new certificate in principal amount equal to the unconverted portion of
the Warrant Certificate.
     8. Fractional Shares and Warrants; Determination of Market Price Per Share
     8.1 Anything contained herein to the contrary notwithstanding, the Company
shall not be required to issue any fraction of a share of Preferred Stock or,
after the Mandatory Conversion, Common Stock, in connection with the exercise of
Warrants. Warrants may not be exercised in such number as would result (except
for the provisions of this paragraph) in the issuance of a fraction of a share
of Preferred Stock or, after the Mandatory Conversion, Common Stock, unless the
Holder is exercising the entire Warrant then owned by the Holder. In such event,
the Company shall, upon the exercise of the Warrant, issue to the Holder the
largest aggregate whole number of shares of Preferred Stock or, after the
Mandatory Conversion, Common Stock, called for thereby upon receipt of the
Exercise Price for the entire Warrant and pay a sum in cash equal to the
remaining fraction of a share of Preferred Stock or, after the Mandatory
Conversion, Common Stock, multiplied by the Preferred Stock Market Price Per
Share (as determined

5

--------------------------------------------------------------------------------

 

pursuant to Section 8.3 below) or, after the Mandatory Conversion, the Common
Stock Market Price Per Share (as determined pursuant to Section 8.2 below) as of
the last business day preceding the date on which the Warrants are presented for
exercise.
     8.2 As used herein, the “Common Stock Market Price Per Share” with respect
to any date shall mean the average closing price per share of Company’s Common
Stock for the ten (10) trading days immediately preceding such date during which
the Common Stock has traded. The closing price for each such day shall be the
closing sale price or, in case no such sale takes place on such day, the closing
price on the last trading day, in either case on the principal securities
exchange on which the shares of Common Stock of the Company are listed or
admitted to trading, the last sale price, or in case no sale takes place on any
such day, the average of the high and low sales prices of the Common Stock on
the Over-the-Counter Bulletin Board (“OTCBB”) or any comparable system, or if
the Common Stock is not reported on OTCBB, or a comparable system, the average
of the closing bid and asked prices as furnished by two members of the National
Association of Securities Dealers, Inc. selected from time to time by the
Company for that purpose. If such bid and asked prices are not available, then
“Common Stock Market Price Per Share” shall be equal to the fair market value of
the Company’s Common Stock as determined in good faith by the Board of Directors
of the Company.
     8.3 “Preferred Stock Market Price Per Share” with respect to any date shall
mean the Common Stock Market Price Per Share (as determined pursuant to
Section 8.2) multiplied by 100.
     9. Notices.
     All notices, requests, demands, claims, and other communications hereunder
shall be in writing and shall be delivered by certified or registered mail
(first class postage pre-paid), guaranteed overnight delivery, or facsimile
transmission if such transmission is confirmed by delivery by certified or
registered mail (first class postage pre-paid) or guaranteed overnight delivery,
to the following addresses and telecopy numbers (or to such other addresses or
telecopy numbers which such party shall subsequently designate in writing to the
other party):
if to the Company to:
ReGen Biologics, Inc.
509 Commerce Street
Franklin Lakes, NJ 07417
Attention: Brion D. Umidi
Telecopy: 201.651.5141
with a copy to:

Pillsbury Winthrop Shaw Pittman LLP
1650 Tysons Boulevard
McLean, VA 22102

6

--------------------------------------------------------------------------------

 

Attention: David C. Main, Esq.
Telecopy: 703.770.7901
if to the Holder to the address set forth on the books of the Company.
     Each such notice or other communication shall for all purposes of this
Agreement be treated as effective or having been given when delivered if
delivered by hand, by messenger or by courier, or if sent by facsimile, upon
confirmation of receipt.
     10. Governing Law
This Warrant Certificate shall be governed by and construed in accordance with
the laws of the State of New York.

7

--------------------------------------------------------------------------------

 

     IN WITNESS WHEREOF, the Company has caused this Warrant Certificate to be
duly executed by its officers thereunto duly authorized and its corporate seal
to be affixed hereon, as of this 2nd day of March, 2007.
REGEN BIOLOGICS, INC.

         
By:
       
 
       
 
  Name: Brion D. Umidi    
 
  Title: Senior Vice President and Chief    
 
  Financial Officer    
 
        Attest:    
 
             
Name:
       
Title:
       

8

--------------------------------------------------------------------------------

 

EXHIBIT A
Certificate of Designations, Preferences and Rights
of Series D Convertible Preferred Stock

9

--------------------------------------------------------------------------------

 

EXHIBIT B
NOTICE OF EXERCISE

         
To:
  ReGen Biologics, Inc.    
 
  509 Commerce Street                       , 20          
 
  Franklin Lakes, NJ 07417    

     The undersigned hereby irrevocably elects to purchase, pursuant to
Section 2 of the Warrant Certificate accompanying this Notice of Exercise,
                     Warrant Shares of the total number of Warrant Shares
issuable to the undersigned pursuant to the accompanying Warrant Certificate,
and herewith makes payment of $                     in payment in full of the
aggregate Exercise Price of such shares.
     Please issue a certificate or certificates representing said Warrant Shares
in the name of the undersigned or in such other name as is specified below:

         
 
       
 
 
 
   
 
            The Warrant Shares shall be delivered to the following:
 
       
 
       
 
       
 
       
 
       
 
       

         
 
       
 
 
 
   
 
  Name of Holder    
 
       
 
       
 
  Signature    
 
       
 
  Address:    
 
       
 
       
 
       
 
       
 
       
 
       

10

--------------------------------------------------------------------------------

 

EXHIBIT C
NOTICE OF CONVERSION

         
To:
  ReGen Biologics, Inc.    
 
  509 Commerce Street                       , 20          
 
  Franklin Lakes, NJ 07417    

     The undersigned hereby irrevocably elects to convert, pursuant to Section 7
of the Warrant Certificate accompanying this Notice of Conversion,
                     Warrant Shares of the total number of Warrant Shares
issuable to the undersigned pursuant to the accompanying Warrant Certificate
into shares of the Preferred Stock /Common Stock (circle one) of the Company
(the “Shares”).
     The number of Shares to be received by the undersigned, calculated in
accordance with the provisions of Section 7.1 of the accompanying Warrant
Certificate, is                     .

         
 
       
 
 
 
   

     Please issue a certificate or certificates representing said Warrant Shares
in the name of the undersigned or in such other name as is specified below:

         
 
       
 
 
 
   
 
        The Warrant Shares shall be delivered to the following:
 
       
 
       
 
       
 
       
 
       
 
       

         
 
       
 
 
 
   
 
  Name of Holder    
 
       
 
       
 
  Signature    
 
       
 
  Address:    
 
       
 
       
 
       
 
       

11